Building Effective Multi-Year Process Development Programs II: Evolution of Technology Platform Decisions… March 30, 2021 BioEconomy, Biomanufacturing, Bioprocessing, Cell Therapy
Building Effective Multi-Year Process Development Programs I: Estimating hMSC Lot Size Ranges for… March 16, 2021 BioEconomy, Biomanufacturing, Bioprocessing, Cell Therapy
Know Your Cost of Goods Recap and Managing Lot Size Estimation November 02, 2020 Cell Therapy, MSCs & Characterization
Final Product Containers for Cell Therapies August 21, 2020 Biomanufacturing, Bioprocessing, Cell Therapy
Interoperative Bioprinting for Cranomaxillofacial Reconstruction with Ibrahim Ozbolat August 07, 2020 Bioprinting & Biofabrication, Tissue Engineering
MSCs as Medical Stockpiled Countermeasures: Cellular “First Responders” for COVID-19 and… May 20, 2020 Biomanufacturing, Cell Therapy, COVID-19
Productivity Metric Considerations in MSC & MSC-EV Manufacturing in Response to COVID-19 May 15, 2020 Biomanufacturing, COVID-19, Exosomes / Extracellular Vesicles
Scalable MSC Manufacturing Matters in a Rapid Response to COVID-19 March 13, 2020 Biomanufacturing, Cell Therapy, Corporate, COVID-19
